+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pyelonephritis Drug"

Pyelonephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Pyelonephritis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Acute Pyelonephritis - Pipeline Insight, 2024 - Product Thumbnail Image

Acute Pyelonephritis - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
Pyelonephritis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pyelonephritis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Acute Pyelonephritis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Acute Pyelonephritis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Pyelonephritis - Pipeline Review, H2 2020 - Product Thumbnail Image

Pyelonephritis - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 150 Pages
  • Global
From
  • 9 Results (Page 1 of 1)
Loading Indicator

Pyelonephritis is a type of kidney infection that is caused by bacteria. It is a serious condition that can lead to permanent kidney damage if left untreated. Treatment for pyelonephritis typically involves antibiotics, and in some cases, hospitalization. Liver and kidney disorders drugs are used to treat a variety of conditions, including pyelonephritis. These drugs can help reduce inflammation, reduce pain, and improve kidney function. Commonly prescribed drugs for pyelonephritis include cephalosporins, fluoroquinolones, and aminoglycosides. The pyelonephritis drug market is a subset of the larger liver and kidney disorders drugs market. It is a rapidly growing market, driven by the increasing prevalence of kidney infections and the need for effective treatments. The market is highly competitive, with a number of companies offering a variety of drugs for the treatment of pyelonephritis. Some of the major companies in the pyelonephritis drug market include Pfizer, Merck, GlaxoSmithKline, AstraZeneca, and Novartis. These companies offer a range of drugs for the treatment of pyelonephritis, including cephalosporins, fluoroquinolones, and aminoglycosides. Show Less Read more